New Strategies for Locally Advanced Breast Cancer: A Review of Inflammatory Breast Cancer and Nonresponders

被引：1
作者：
Malhotra, Simran [1 ]
Tadros, Audree B. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surger, Breast Serv, 300 East 66th St, New York, NY 10065 USA
来源：
CLINICAL BREAST CANCER | 2024年 / 24卷 / 04期
关键词：
Breast cancer-related lymphedema; Breast surgery; Lymphatic reconstruction; Neoadjuvant systemic therapy; Radiotherapy; LYMPH-NODE TRANSFER; NEOADJUVANT CHEMOTHERAPY; SACITUZUMAB GOVITECAN; BIOPSY; RECONSTRUCTION; EFFICACY; THERAPY; BURDEN; RISK; MRI;
D O I：
10.1016/j.clbc.2024.01.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This review explores the new strategies around the management of locally advanced breast cancer (LABC), particularly for nonresponsive tumors and/or initially unresectable tumors at diagnosis, inclusive of inflammatory breast cancer. Nonresponders to neoadjuvant systemic therapy present a unique clinical challenge. Emerging medical therapeutics as well as considerations for use of radiotherapy and/or surgery in this setting are discussed. Specifically, the use of neoadjuvant radiotherapy for LABC and lymphedema prevention with lymphatic reconstruction following axillary lymph node dissection are reviewed.
引用
收藏
页码：301 / 309
页数：9
相关论文
共 70 条
  • [1] Contemporary surgical management of inflammatory breast cancer: a narrative review
    Adesoye, Taiwo
    Irwin, Shelby
    Sun, Susie X.
    Lucci, Anthony
    Teshome, Mediget
    [J]. CHINESE CLINICAL ONCOLOGY, 2021, 10 (06)
  • [2] [Anonymous], 2023, A randomized study of preoperative chemotherapy, pembrolizumab and no, low or high dose radiation in node-positive, HER2-negative breast cancer: clinicaltrials.gov
  • [3] AstraZeneca, A phase 3 open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP compared to ddAC-THP in participants with high-risk HER2-positive early-stage breast cancer (DESTINYBreast11)
  • [4] Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
    Bardia, A.
    Hurvitz, S. A.
    Tolaney, S. M.
    Loirat, D.
    Punie, K.
    Oliveira, M.
    Brufsky, A.
    Sardesai, S. D.
    Kalinsky, K.
    Zelnak, A. B.
    Weaver, R.
    Traina, T.
    Dalenc, F.
    Aftimos, P.
    Lynce, F.
    Diab, S.
    Cortes, J.
    O'Shaughnessy, J.
    Dieras, V
    Ferrario, C.
    Schmid, P.
    Carey, L. A.
    Gianni, L.
    Piccart, M. J.
    Loibl, S.
    Goldenberg, D. M.
    Hong, Q.
    Olivo, M. S.
    Itri, L. M.
    Rugo, H. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16) : 1529 - 1541
  • [5] Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
    Bardia, A.
    Mayer, I. A.
    Vahdat, L. T.
    Tolaney, S. M.
    Isakoff, S. J.
    Diamond, J. R.
    O'Shaughnessy, J.
    Moroose, R. L.
    Santin, A. D.
    Abramson, V. G.
    Shah, N. C.
    Rugo, H. S.
    Goldenberg, D. M.
    Sweidan, A. M.
    Iannone, R.
    Washkowitz, S.
    Sharkey, R. M.
    Wegener, W. A.
    Kalinsky, K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (08) : 741 - 751
  • [6] Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
    Bardia, Aditya
    Mayer, Ingrid A.
    Diamond, Jennifer R.
    Moroose, Rebecca L.
    Isakoff, Steven J.
    Starodub, Alexander N.
    Shah, Nikita C.
    O'Shaughnessy, Joyce
    Kalinsky, Kevin
    Guarino, Michael
    Abramson, Vandana
    Juric, Dejan
    Tolaney, Sara M.
    Berlin, Jordan
    Messersmith, Wells A.
    Ocean, Allyson J.
    Wegener, William A.
    Maliakal, Pius
    Sharkey, Robert M.
    Govindan, Serengulam V.
    Goldenberg, David M.
    Vahdat, Linda T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) : 2141 - +
  • [7] LYMPHATIC MICROSURGICAL PREVENTING HEALING APPROACH (LYMPHA) FOR PRIMARY SURGICAL PREVENTION OF BREAST CANCER-RELATED LYMPHEDEMA: OVER 4 YEARS FOLLOW-UP
    Boccardo, Francesco
    Casabona, Federico
    DeCian, Franco
    Friedman, Daniele
    Murelli, Federica
    Puglisi, Maria
    Campisi, Corrado C.
    Molinari, Lidia
    Spinaci, Stefano
    Dessalvi, Sara
    Campisi, Corradino
    [J]. MICROSURGERY, 2014, 34 (06) : 421 - 424
  • [8] Effect of preoperative rescue concomitant FUN/XUN-based chemo-radiotherapy for neoadjuvant chemotherapy-refractory breast cancer
    Bourgier, Celine
    Ghorbel, Ismael
    Heymann, Steve
    Barhi, Mane
    Mazouni, Chafika
    Al Ghuzlan, Abir
    Balleyguier, Corinne
    Marsiglia, Hugo
    Delaloge, Suzette
    [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 103 (02) : 151 - 154
  • [9] Center MDAC, 2023, clinicaltrials.gov
  • [10] Symptom palliation of hypofractionated radiotherapy for patients with incurable inflammatory breast cancer
    Choi, Hoon Sik
    Jang, Hong Seok
    Kang, Ki Mun
    Choi, Byung-ock
    [J]. RADIATION ONCOLOGY, 2019, 14 (1)
1234567